Allergy practice worldwide - A report by the World Allergy Organization Specialty and Training Council

Allergy and Clinical Immunology International

Volumn 18, Issue 1, 2006, Pages 4-10

  Warner, John O ^c   Kaliner, Michael A ^a   Crisci, Carlos D ^c   del Giacco, Sergio ^c   Frew, Anthony J ^c   Gh, Liu ^c   Maspero, Jorge ^c   Moon, Hee Bom ^c   Nakagawa, Takemasa ^c   Potter, Paul C ^c   Rosenwasser, Lanny J ^c   Singh, Anand B ^c   Valovirta, Erkka ^c   van Cauwenberge, Paul ^c   Henley, Karen ^b  

^a Institute for Asthma and Allergy   (United States)

^b World Allergy Organization   (United States)

^c NONE

Author keywords

Allergy; International; Standard of care; Survey; Training

Indexed keywords

ALLERGY; ARTICLE; CLINICAL PATHWAY; CLINICAL PRACTICE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EDUCATION PROGRAM; EPIDEMIC; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICAL SPECIALIST; MEDICAL STUDENT; PATIENT CARE; PHYSICIAN; POPULATION RESEARCH; PRIMARY HEALTH CARE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; TERTIARY HEALTH CARE;

EID: 33644546381     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.18.1.4     Document Type: Article

References (17)

1. ISAAC Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet 1998; 351:1225-1232
2. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self reported asthma attacks and use of asthma medication in the European community respiratory health survey ECRHS. Eur Respir J 1996; 9:687-695
3. Grundy J, Matthews S, Bateman B, Dean T, Arshad, SH. Rising prevalence of allergy to peanut in children: Data from two sequential cohorts. J Allergy Clin Immunol 2002; 110:784-789
4. Sheikh A, Alves B. Hospital admissions for anaphylaxis: Time trend study. BMJ 2000; 320:1441
5. Garabrant DH, Schweitzer S. Epidemiology of latex sensitisation and allergies in health care workers. J Allergy Clin Immunol 2002; 110:582-595
6. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1:305-310
7. Bousquet J. Allergy as a global problem: Think globally act globally. Allergy 2000; 57:661-662
8. Steinman H, Donson H, Kawalski, M Toerien A, Potter PC. Bronchial hyper-responsiveness in urban, periurban and rural South African children. Pediatr Allergy Immunol 2003; 14:383-393
9. Maziak W, von Mutius E, Keil U, Hirsch T, Leopold W, Rzehak P, Behrens T, Weiland SK. Predictors of health care utilization of children with asthma in the community. Pediatr Allergy Immunol 2004:14:166-171
10. Glaxo Wellcome Inc. Asthma in America nationals survey. Washington DC: Glaxo Wellcome Inc., 1998
11. Weiss KB, Gurgen PJ, Hogson TA. An economic evaluation of asthma in the United States. New Engl J Med 1992; 326:862-866
12. Royal College of Physicians Working Party on the provision of allergy services in the UK. Allergy: The unmet need. A blueprint for better patient care. London: Royal College of Physicians, 2003
13. House of Commons Health Committee. HC 696-I The Provision of Allergy Services. London: The Stationery Office, 2004
14. Warner JO. The allergy paradox. Pediatr Allergy Immunol 2004; 15:287-288
15. Grupp-Phelan J, Lozars P, Fishman P. Health care utilization and cost in children with asthma and selected comorbidities. J Asthma 2001; 38:363-373
16. National Service Framework for Children, Young People and Maternity Services. London: Department of Health Publications, 2004
17. van den Akker-van Marle ME, Bruil J, Detmar SB. Evaluation of cost disease: Assessing the burden to society of asthma in children in the European Union. Allergy 2005; 60:140-149